Developmental-Behavioral Pediatrics, Floating Hospital for Children, Tufts Medical Center, Boston, Mass.
Developmental-Behavioral Pediatrics, Floating Hospital for Children, Tufts Medical Center, Boston, Mass.
Acad Pediatr. 2017 Jul;17(5):464-470. doi: 10.1016/j.acap.2017.01.016. Epub 2017 Mar 7.
In their recommendations on screening for autism and developmental disabilities, the American Academy of Pediatrics recommends referral subsequent to a positive screening result. In this article, we argue that positive screening results are not always sufficient to justify a referral. We show that although positive predictive values are often low, they actually overstate the probability of having a disorder for many children who screen positive. Moreover, recommended screening thresholds are seldom set to ensure that the benefits of referral will equal or exceed the costs and risk of harm, which is a necessary condition for an optimal threshold in decision analysis. Drawing on recent recommendations for the Institute of Medicine/National Academy of Medicine, we discuss the implications of this argument for pediatric policy, education, and practice. In particular, we recommend that screening policies be revised to ensure that the costs and benefits of actions recommended in the event of a positive screen are appropriate to the screening threshold. We recommend greater focus on clinical decision-making in the education of physicians, including shared decision-making with patients and their families. Finally, we recommend broadening the scope of screening research to encompass not only the accuracy of specific screening instruments, but also their ability to improve decision-making in the context of systems of care.
在关于自闭症和发育障碍筛查的建议中,美国儿科学会建议在阳性筛查结果后进行转介。在本文中,我们认为阳性筛查结果并不总是足以证明转介的合理性。我们表明,尽管阳性预测值通常较低,但实际上它们高估了许多筛查阳性儿童出现障碍的概率。此外,推荐的筛查阈值很少设置为确保转介的收益等于或超过成本和伤害风险,这是决策分析中最优阈值的必要条件。借鉴最近美国医学研究所/国家科学院的建议,我们讨论了这一论点对儿科政策、教育和实践的影响。特别是,我们建议修订筛查政策,以确保在阳性筛查结果的情况下推荐的行动的成本和收益与筛查阈值相适应。我们建议在医生的教育中更加注重临床决策,包括与患者及其家属共同决策。最后,我们建议扩大筛查研究的范围,不仅包括特定筛查工具的准确性,还包括它们在医疗保健系统背景下改善决策的能力。